The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | The role of the National Lung Cancer Audit in lung cancer care in the UK
Neal Navani, MA, MRCP, MSc, PhD, University College London Hospitals NHS Foundation Trust, London, UK, explains the background of the National Lung Cancer Audit (NLCA) and talks on its current role in lung cancer care in the UK. The aim of the NLCA is to collect comprehensive data on every lung cancer patient in the country and has so far resulted in significant improvements in patient outcomes and clinical care. Dr Navani suggests that in the future, the NLCA could work towards the use of more real-time data and create dashboards for NHS trusts to use to implement local quality improvement measures, as well as broadening the remit of the number of metrics collected by the NLCA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Honoraria for non-promotional educational talks or advisory boards from Amgen, Astra Zeneca, Boehringer ingelheim, Bristol Myers Squibb, Fujifilm, Guardant Health, Intuitive, Janssen, Lilly, Merck Sharp & Dohme, Olympus, OncLive, PeerVoice, Pfizer, and Takeda.
